MacroGenics, Inc.
MGNXNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $143.09M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.29$5.08
- Volume (live)
- -
- Avg. volume (3M)
- 698.21K
MacroGenics (MGNX) Stock Price & Financial Analysis
MacroGenics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.13 - $3.57 |
|---|---|
| 52-Week High | $5.08 |
| 52-Week Low | $1.29 |
| Open | $3.55 |
| Volume (last close) | 4.01M |
| Average Volume (3M) | 698.21K |
| Revenue (TTM) | 167.67M |
|---|---|
| Net Income (TTM) | -14.59M |
| Free Cash Flow (TTM) | -65.54M |
| EPS (TTM) | −$0.23 |
| Profit Margin | -8.70% |
| Operating Margin | -24.30% |
| Return on Equity (ROE) | -34.04% |
| Debt to Equity | 0.82 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 143.09M |
|---|---|
| Shares Outstanding | 63.59M |
| Price to Sales (P/S) | 0.85 |
| Price to Book (P/B) | 3.34 |
| EV/EBITDA | -1.86 |
| 50-Day MA | $3.92 |
|---|---|
| 200-Day MA | $3.38 |
| 1-Year Change | +98.36% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
MacroGenics at a Glance
As of the Oct 23, 2026 close, MacroGenics (MGNX) has a market capitalization of $143.09M. The stock trades at 0.8× sales. Over the trailing twelve months it lost $14.59M on revenue of $167.67M and burned $65.54M of free cash flow. Revenue fell 6.3% year over year.
As of its latest reported balance sheet, it holds $113.91M in cash and securities against $35.09M of debt, a net cash position of $78.81M.
MacroGenics does not currently pay a dividend.
The share price is up 98.4% over the past year. At $2.25 (the Oct 23, 2026 close) it sits within its 52-week range of $1.29 to $5.08, below its 200-day moving average of $3.38.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $7.00, 211.1% above the Oct 23, 2026 close.
Frequently Asked Questions About MacroGenics
What is the current stock price for MGNX?
As of the Oct 23, 2026 close, MGNX stock trades at $2.25. The 52-week range is $1.29–$5.08, with a day range of $2.13–$3.56.
What is the P/E ratio for MGNX?
The P/E ratio (Price-to-Earnings) for MGNX is shown in the Key Statistics section. This valuation metric helps compare MacroGenics, Inc. to industry peers.
Does MGNX pay dividends?
MacroGenics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MGNX?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for MGNX is Hold. The average 12-month price target is $7.00, a 211.1% upside from the Oct 23, 2026 close of $2.25.
What is the market cap of MGNX?
As of the Oct 23, 2026 close, MacroGenics's market capitalization is $143.1M, classifying it as a micro-cap company. MacroGenics operates in the Healthcare sector within the Biotechnology industry.